Indivior Pharmaceuticals Inc Financial Ratios — INDV Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	304.26	71.18	39.03	24.32	3.4	5.46	22.07	9.21	-10.19	14.18	-3.06	0.15	- -	- -
Return on Assets (%)	- -	108.78	99.49	68.71	27.08	3.26	4.37	18.39	8.38	-9.3	12.19	-2.44	-7.14	0.46	16.69
Return on Capital (%)	- -	304.26	71.18	28.83	16.77	3.17	4.69	18.83	8.73	- -	- -	- -	- -	85.4	304.32
Return on Invested Capital (%)	- -	309.69	- -	299.05	79.65	15.88	26.02	92.76	29.64	- -	- -	- -	- -	86.67	139.01
Gross Margin (%)	93.54	92.98	91.45	91.48	90.43	89.89	90.48	87.26	82.17	85.01	83.94	83.24	84.08	80.56	80.15
EBITDA Margin (%)	69.54	66.02	57.15	50.4	34.12	14.08	17.66	33.03	22.68	-24.11	22.88	25.64	23.97	22.05	23
Operating Margin (%)	69.54	66.02	57.15	50.4	34.12	14.08	17.66	31.44	22.68	-24.11	22.88	23.86	22.6	19.7	21.39
Incremental Operating Margin (%)	- -	14.12	153.66	131.68	213.86	-447.73	125.71	-139.77	62.73	- -	234.03	30.91	16.67	-13.68	60.78
Pretax Margin (%)	69.54	66.02	57.15	50.31	28.11	9.26	12.53	27.66	22.93	-26.74	24.02	-9.88	-13.27	1.68	19.29
Profit Margin (%)	48.96	45.33	40.21	36.14	22.49	3.31	5.31	27.36	17.07	-22.87	25.92	-4.88	-11.53	0.59	16.95
Net Income to Common Margin (%)	48.96	45.33	40.21	36.14	22.49	3.31	5.31	27.36	17.07	-22.87	25.92	-4.88	-11.53	0.59	16.95
Effective Tax Rate (%)	29.59	31.33	29.64	28.16	20	64.29	57.66	1.08	25.56	- -	- -	- -	- -	65	12.13
Dvd Payout Ratio (%)	- -	- -	48.88	124.07	10.09	197.14	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	304.26	36.39	-9.39	21.87	-3.3	5.46	22.07	9.21	-10.19	14.18	-3.06	0.15	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	736	605	535	482	241	293	285	286	277	283	375	351
ST Debt	- -	- -	- -	17	34	101	5	4	9	12	11	11	12	28	39
LT Debt	- -	- -	- -	719	571	434	477	237	284	273	275	266	271	347	312
Total Debt/EBITDA	- -	- -	- -	1.31	1.75	3.59	2.5	0.73	1.65	-1.83	1.58	1.2	1.08	1.43	1.23
Net Debt/EBITDA	-0.01	-0.03	-0.01	0.72	0.4	-1.05	-1.97	-2.06	-4.62	4	-4.75	-2.31	-0.29	0.05	0.44
Total Debt/EBIT	- -	- -	- -	1.31	1.75	3.59	2.5	0.76	1.65	-1.83	1.58	1.29	1.15	1.6	1.32
Net Debt/EBIT	-0.01	-0.03	-0.01	0.72	0.4	-1.05	-1.97	-2.16	-4.62	4	-4.75	-2.48	-0.31	0.06	0.47
EBITDA to Interest Expense	- -	- -	- -	562	6.65	3.39	5.22	11.86	8.09	-6.5	6.96	8.56	7.49	6.39	6.33
EBITDA-CapEx/Interest Expense	- -	- -	- -	536	6.06	2.59	4.05	10.39	7.77	-6.67	5.65	8.37	5.97	5.63	4.84
EBIT to Interest Expense	- -	- -	- -	562	6.65	3.39	5.22	11.29	8.09	-6.5	6.96	7.96	7.06	5.71	5.89
Interest Expense	- -	- -	- -	1	52	44	37	28	22	24	26	27	35	41	45
Common Equity/Total Assets	45.44	26.03	288.5	111.91	110.89	84.53	76.45	89.72	92.13	90.4	82.31	77.5	-12.9	-28.95	-15.07
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	359.09	135.89	332.93	135.47	521.57	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	45.74	34.73	27.87	30.08	14.55	15.65	16.36	15.33	16.14	483.93	-5,783.33	183.53
Long-Term Debt/Total Assets (%)	- -	- -	- -	96.25	60.94	35.9	33.03	15.32	17.19	17.83	15.01	15.04	15.4	26.37	25.98
Total Debt/Equity (%)	- -	- -	- -	-154.95	-216.85	-181.36	-237.44	365.15	140.19	347.56	140.89	543.14	-147.4	-111.28	-354.55
Total Debt/Capital (%)	- -	- -	- -	46.82	36.8	34.36	30.39	14.79	16.14	17.08	15.94	16.81	505.36	-6,250	206.47
Total Debt/Total Assets (%)	- -	- -	- -	98.53	64.57	44.25	33.38	15.58	17.74	18.62	15.61	15.66	16.08	28.5	29.23
Net Debt to Equity	-2.76	-17.24	10.61	-85.26	-49.46	53.22	187.68	-1,034.85	-393.78	-760.98	-423.65	-1,047.06	39.58	-4.15	-125.25
Net Debt/Capital (%)	-2.83	-20.83	-0.57	32.63	11.72	-18.15	-52.7	-96.88	-109.01	-76.94	-124.28	-61.1	29.23	-4.31	-496
EBITDA	872	884	695	562	346	149	193	332	178	-156	181	231	262	262	285
EBITDA-CapEx	847	881	692	536	315	114	150	291	171	-160	147	226	209	231	218
Operating Income (Loss)	872	884	695	562	346	149	193	316	178	-156	181	215	247	234	265

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.02	0.06	0.02	0.72	0.77	0.67	1.01	1.13	1.43	1.43	1.37	0.88	0.32	0.35	0.21
Current Ratio	1.08	0.88	0.51	1.22	1.2	0.96	1.43	1.62	1.83	1.98	1.8	1.24	0.98	0.9	0.71
Quick Ratio	0.02	0.06	0.02	0.72	0.77	0.67	1.01	1.13	1.69	1.43	1.37	0.88	0.32	0.66	0.49
CFO/Avg Current Liab	- -	2.47	1.87	0.96	0.6	0.5	0.31	0.36	0.19	-0.29	0.5	- -	-0.26	0.03	-0.03
Common Equity/Total Assets	45.44	26.03	288.5	111.91	110.89	84.53	76.45	89.72	92.13	90.4	82.31	77.5	-12.9	-28.95	-15.07
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	359.09	135.89	332.93	135.47	521.57	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	45.74	34.73	27.87	30.08	14.55	15.65	16.36	15.33	16.14	483.93	-5,783.33	183.53
Long-Term Debt/Total Assets (%)	- -	- -	- -	96.25	60.94	35.9	33.03	15.32	17.19	17.83	15.01	15.04	15.4	26.37	25.98
Total Debt/Equity (%)	- -	- -	- -	-154.95	-216.85	-181.36	-237.44	365.15	140.19	347.56	140.89	543.14	-147.4	-111.28	-354.55
Total Debt/Capital (%)	- -	- -	- -	46.82	36.8	34.36	30.39	14.79	16.14	17.08	15.94	16.81	505.36	-6,250	206.47
Total Debt/Total Assets (%)	- -	- -	- -	98.53	64.57	44.25	33.38	15.58	17.74	18.62	15.61	15.66	16.08	28.5	29.23
CFO/Total Liabilities	234.43	210.19	160.77	36.01	26.32	27.06	17.91	20.46	10.46	-13.32	21.67	-0.23	-15.37	2.18	-2.08
CFO/CapEx	28.6	288.67	263.67	16.92	10.32	11.63	6.86	7.39	21.57	-48.25	10.38	-0.8	-5.66	1.16	-0.4
Altman's Z-Score	9.81	9.55	8.89	4.23	5.14	3.53	4.12	3.47	2.78	2.26	3.31	3.25	1.48	1.53	3.29

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	5.04	5.5	6.74	6.13	5.66	4.73	3.82	3.41	3.49	4.15	4.27	4.61	4.68	4.89
Days Sales Outstanding	- -	72.37	66.34	54.18	59.57	64.51	77.14	95.52	107.18	104.65	87.9	85.48	79.14	78.04	74.68
Inventory Turnover	- -	2.85	2.97	2.47	2.18	2.4	2.24	1.97	1.85	1.17	1.35	1.44	1.4	1.48	1.48
Days Inventory Outstanding	- -	128.14	122.84	147.92	167.45	151.8	163.2	185.35	196.84	312.32	270.16	252.6	261.16	247.28	247.04
Accounts Payable Turnover	- -	2.7	2.38	2.41	3.71	3.33	3.15	3.54	3.14	3.97	5.61	5.76	5.42	5.37	4.02
Accounts Payable Turnover Days	- -	134.97	153.23	151.48	98.27	109.5	115.85	103.1	116.26	92.03	65.08	63.34	67.38	67.94	90.84
Cash Conversion Cycle	- -	65.54	35.94	50.62	128.75	106.81	124.49	177.77	187.76	324.94	292.98	274.74	272.92	257.38	230.88
Inventory to Cash Days	- -	-55.77	-56.5	-93.74	-107.87	-87.29	-86.06	-89.83	-89.66	-207.67	-182.25	-167.12	-182.02	-169.24	-172.36
Inventories	32	34	36	41	48	41	52	78	73	93	95	114	135	178	155
Raw Materials	6	8	8	7	11	9	14	31	28	38	34	27	38	33	31
Work In Process	14	11	15	9	21	16	19	24	22	19	28	42	34	51	49
Finished Goods	12	15	13	25	16	16	19	23	23	36	33	45	63	94	75
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	1,617	1,955	2,556	3,966	982	378	1,074	2,513	3,024	2,097	1,645	4,485
- Cash & Cash Equivalents	7	25	7	331	467	692	863	924	1,060	858	1,102	774	316	319	195
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	736	605	535	482	241	293	285	286	277	283	375	351
Enterprise Value	-7	-25	-7	2,022	2,093	2,399	3,585	299	-389	501	1,697	2,408	1,970	1,700	4,641
Total Capital	254	145	1,229	1,572	1,644	1,557	1,586	1,629	1,815	1,669	1,794	1,648	56	-6	170
Total Debt/Capital (%)	- -	- -	- -	46.82	36.8	34.36	30.39	14.79	16.14	17.08	15.94	16.81	505.36	-6,250	206.47
Total Debt / EV	- -	- -	- -	0.36	0.29	0.22	0.13	0.81	-0.75	0.57	0.17	0.12	0.14	0.22	0.08
EV/Sales	- -	- -	- -	1.81	2.06	2.27	3.28	0.3	- -	0.77	2.14	2.67	1.8	1.43	3.75
EV/EBITDA	- -	- -	- -	3.6	6.05	16.1	18.58	0.9	- -	- -	9.37	10.42	7.52	6.49	16.28
EV/EBIT	- -	- -	- -	3.6	6.05	16.1	18.58	0.95	- -	- -	9.37	11.2	7.97	7.26	17.51
EV/Cash Flow to Firm	- -	- -	- -	4.59	5.79	5.67	11.54	0.9	- -	- -	4.45	249.44	- -	33.76	370.1
EV/Free Cash Flow to Firm	- -	- -	- -	4.33	5.33	5.24	10.14	0.8	- -	- -	4.09	164.32	- -	20.89	58.35
Diluted Market Cap	- -	- -	- -	1,629	1,994	2,638	4,117	1,014	391	1,129	2,660	3,167	2,165	1,645	4,594
Diluted Enterprise Value	-7	-25	-7	2,034	2,132	2,481	3,736	331	-376	556	1,844	2,670	2,132	1,701	4,750
EV per Share	- -	- -	- -	14.07	14.56	16.66	24.86	2.05	- -	3.42	11.65	17.32	14.35	12.85	37.13
TTM Sales	1,254	1,339	1,216	1,115	1,014	1,058	1,093	1,005	785	647	791	901	1,093	1,188	1,239
TTM EBITDA	872	884	695	562	346	149	193	332	178	-156	181	231	262	262	285
TTM Operating Income	872	884	695	562	346	149	193	316	178	-156	181	215	247	234	265
TTM Cash Flow to Firm	715	866	791	441	362	423	311	331	167	-172	381	10	-270	50	13
TTM Free Cash Flow to Firm	740	869	794	467	393	458	354	372	174	-168	415	15	-217	81	80

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	3.5	5.68	5.97	12.18	2.95	2.47	-5.97	6.87	3,167.17	-8.77	24.55	114.86
EV/EBIT	- -	- -	- -	3.6	6.05	16.1	18.58	0.95	- -	- -	9.37	11.2	7.97	7.26	17.51
Enterprise Value	-7	-25	-7	2,022	2,093	2,399	3,585	299	-389	501	1,697	2,408	1,970	1,700	4,641
Low Price	- -	- -	- -	10.65	10	9.8	17.5	4.75	1.75	2.13	6.65	3.13	14.38	7.33	7.62
EV/Sales	- -	- -	- -	1.81	2.06	2.27	3.28	0.3	- -	0.77	2.14	2.67	1.8	1.43	3.75
EV/EBITDA	- -	- -	- -	3.6	6.05	16.1	18.58	0.9	- -	- -	9.37	10.42	7.52	6.49	16.28
Price/Earnings	- -	- -	- -	4.01	8.57	73.02	68.38	3.57	2.82	- -	12.26	- -	1,046	234.94	21.36
Price/Earnings Average	- -	- -	- -	3.89	9.89	65.16	54.76	11.41	4.39	-5.15	8.49	-57.36	-22.07	276.83	11.06
Price/Earnings High	- -	- -	- -	4.28	13.11	92.97	68.38	17.77	8.79	-9.47	12.83	-69.51	-28.88	438.89	22.62
Price/Earnings Low	- -	- -	- -	3.8	6.3	40.31	43.52	2.51	1.9	-2.11	4.73	-9.89	-15.67	138.55	4.54
Price/Book Value	- -	- -	- -	1.93	1.88	2.5	3.59	0.71	0.25	0.78	1.67	2.21	-9.24	-4.32	-24.78
Price/Book Value Average	- -	- -	- -	1.87	2.17	2.23	2.88	2.26	0.39	0.55	1.15	1.84	-12.25	-5.09	-12.84
Price/Book Value High	- -	- -	- -	2.06	2.88	3.18	3.59	3.52	0.77	1.01	1.74	2.23	-16.03	-8.06	-26.24
Price/Book Value Low	- -	- -	- -	1.83	1.38	1.38	2.29	0.5	0.17	0.23	0.64	0.32	-8.7	-2.55	-5.26
Price/Tangible Book Value	- -	- -	- -	-2.86	-5.73	-6.76	-13.44	-54.54	2.76	53.72	20.77	-159.13	-10.23	-4.78	-44.41
Price/Tangible Book Value Average	- -	- -	- -	-2.77	-6.61	-6.03	-10.77	-174.37	4.29	38.11	14.39	-132.82	-13.56	-5.63	-23
Price/Tangible Book Value High	- -	- -	- -	-3.05	-8.77	-8.61	-13.44	-271.47	8.6	70.06	21.73	-160.96	-17.75	-8.93	-47.03
Price/Tangible Book Value Low	- -	- -	- -	-2.7	-4.21	-3.73	-8.56	-38.38	1.86	15.61	8.01	-22.9	-9.63	-2.82	-9.43
Price/Sales	- -	- -	- -	1.45	1.93	2.42	3.63	0.98	0.48	1.66	3.18	3.36	1.92	1.38	3.62
Price/Sales Average	- -	- -	- -	1.4	2.22	2.16	2.91	3.12	0.75	1.18	2.2	2.8	2.54	1.63	1.88
Price/Sales High	- -	- -	- -	1.55	2.95	3.08	3.63	4.86	1.5	2.17	3.32	3.39	3.33	2.59	3.83
Price/Sales Low	- -	- -	- -	1.37	1.42	1.33	2.31	0.69	0.32	0.48	1.22	0.48	1.81	0.82	0.77
Price/Cash Flow	- -	- -	- -	3.67	6.11	6.28	13.44	3.24	2.5	-5.57	7.12	-755.88	-6.99	45.68	-166.11
Price/Cash Flow Average	- -	- -	- -	3.56	7.05	5.6	10.77	10.36	3.9	-3.95	4.93	-630.91	-9.27	53.83	-86.04
Price/Cash Flow High	- -	- -	- -	3.92	9.34	7.99	13.44	16.13	7.8	-7.26	7.45	-764.57	-12.13	85.34	-175.93
Price/Cash Flow Low	- -	- -	- -	3.48	4.49	3.47	8.56	2.28	1.69	-1.62	2.74	-108.78	-6.58	26.94	-35.28
Price/Free Cash Flow Average	- -	- -	- -	3.39	6.55	5.33	9.75	9.42	3.85	-4.24	4.76	2,643.55	-11.63	28.92	59.5
Price/Free Cash Flow High	- -	- -	- -	3.73	8.69	7.6	12.18	14.67	7.7	-7.79	7.19	3,203.57	-15.21	45.85	121.65
Price/Free Cash Flow Low	- -	- -	- -	3.31	4.18	3.3	7.75	2.07	1.66	-1.74	2.65	455.78	-8.26	14.47	24.39
EV/Sales Average	- -	- -	- -	1.77	2.36	2.01	2.56	2.44	- -	0.29	1.17	2.25	2.51	1.68	2
EV/Sales High	- -	- -	- -	1.91	3.08	2.93	3.28	4.18	0.52	1.28	2.29	2.84	3.3	2.63	3.96
EV/Sales Low	- -	- -	- -	1.74	1.55	1.19	1.96	0.01	- -	- -	0.19	- -	1.78	0.86	0.89
EV/EBITDA Average	-0.01	-0.03	-0.01	3.51	6.92	14.25	14.48	7.4	-1	-1.21	5.11	8.77	10.49	7.61	8.7
EV/EBITDA High	-0.01	-0.03	-0.01	3.79	9.04	20.78	18.58	12.66	2.31	-5.31	10.02	11.09	13.76	11.94	17.21
EV/EBITDA Low	-0.01	-0.03	-0.01	3.44	4.55	8.42	11.1	0.02	-2.88	1.67	0.84	-0.27	7.41	3.92	3.89
EV/EBIT Average	-0.01	-0.03	-0.01	3.51	6.92	14.25	14.48	7.77	-1	-1.21	5.11	9.43	11.12	8.52	9.36
EV/EBIT High	-0.01	-0.03	-0.01	3.79	9.04	20.78	18.58	13.3	2.31	-5.31	10.02	11.91	14.6	13.37	18.51
EV/EBIT Low	-0.01	-0.03	-0.01	3.44	4.55	8.42	11.1	0.02	-2.88	1.67	0.84	-0.29	7.86	4.38	4.18
Last Price	- -	- -	- -	11.25	13.6	17.75	27.5	6.75	2.6	7.33	17.25	21.75	15.27	12.43	35.88
High Price	- -	- -	- -	12	20.8	22.6	27.5	33.6	8.1	9.56	18.05	22	26.5	23.22	38
Enterprise Value Average	-7	-25	-7	1,971	2,393	2,123	2,795	2,456	-179	189	925	2,027	2,748	1,994	2,479
Enterprise Value High	-7	-25	-7	2,130	3,127	3,097	3,585	4,203	411	828	1,813	2,561	3,606	3,128	4,906
Enterprise Value Low	-7	-25	-7	1,936	1,575	1,254	2,143	8	-512	-261	153	-62	1,941	1,026	1,108

Shares Outstanding	144	144	144	144	144	144	144	146	146	147	140	136	137	125	125
Diluted Weighted Avg Shares	147	147	144	145	147	149	150	150	150	154	154	146	142	132	128
Basic Weighted Avg Shares	147	147	144	144	144	144	144	145	145	147	146	139	137	132	125
Revenue per Share	8.51	9.09	8.46	7.76	7.06	7.35	7.58	6.91	5.4	4.41	5.43	6.48	7.96	8.98	9.91
EBITDA per Share	5.92	6	4.84	3.91	2.41	1.03	1.34	2.28	1.22	-1.06	1.24	1.66	1.91	1.98	2.28
Operating Income per Share	5.92	6	4.84	3.91	2.41	1.03	1.34	2.17	1.22	-1.06	1.24	1.55	1.8	1.77	2.12
Basic EPS, GAAP	4.17	4.12	3.4	2.8	1.59	0.24	0.4	1.89	0.92	-1.01	1.41	-0.32	-0.92	0.05	1.68
Basic EPS from Cont Ops	4.17	4.12	3.4	2.8	1.59	0.24	0.4	1.89	0.92	-1.01	1.41	-0.32	-0.92	0.05	1.68
Diluted EPS, GAAP	4.17	4.12	3.4	2.78	1.56	0.24	0.39	1.83	0.89	-0.96	1.33	-0.3	-0.89	0.05	1.64
Diluted EPS from Cont Ops	4.17	4.12	3.4	2.78	1.56	0.24	0.39	1.83	0.89	-0.96	1.33	-0.31	-0.89	0.05	1.64
Dividend per Share	- -	- -	1.66	3.48	0.16	0.48	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	4.85	5.88	5.5	3.06	2.23	2.83	2.05	2.08	1.04	-1.32	2.42	-0.03	-2.18	0.27	-0.22
Free Cash Flow per Basic Share	4.68	5.86	5.48	2.88	2.01	2.58	1.75	1.8	0.99	-1.34	2.19	-0.06	-2.57	0.04	-0.75
Cash & Equivalents per Share	0.05	0.17	0.05	2.3	3.25	4.81	5.98	6.35	7.29	5.85	7.57	6.42	2.99	2.42	1.56
Book Value per Share	1.72	0.98	8.55	5.82	7.23	7.1	7.65	9.54	10.47	9.44	10.35	9.86	-1.65	-2.88	-1.45
Tangible Book Value per Share	0.81	0.19	-1.11	-3.94	-2.37	-2.63	-2.05	-0.12	0.94	0.14	0.83	-0.14	-1.49	-2.6	-0.81

Indivior Pharmaceuticals Inc

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)